| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 1.69e-06 | 4 | 151 | 3 | GO:0030197 | |
| GeneOntologyMolecularFunction | choline-phosphate cytidylyltransferase activity | 5.68e-05 | 2 | 151 | 2 | GO:0004105 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR BCL9L MAP1A RRP1B NACA BLNK SPAG9 BCOR IFI16 CREBBP RGS14 KMT2C TAF9B MAVS SNAP91 TLE4 MDC1 MYOCD CAMTA1 MUC1 LCOR | 1.76e-04 | 1160 | 151 | 21 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L RRP1B NACA BCOR IFI16 CREBBP KMT2C TAF9B TLE4 MYOCD CAMTA1 MUC1 LCOR | 3.51e-04 | 562 | 151 | 13 | GO:0003712 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR MAP1A TRPM7 FHOD3 SPAG9 DCX PDLIM5 CEP350 SPATC1 RGS14 MTUS1 ANLN FMN1 DCLK2 IQCJ-SCHIP1 CAMSAP2 TNS1 PACSIN2 CAP2 | 6.44e-04 | 1099 | 151 | 19 | GO:0008092 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX6 TPR MAF1 KLF8 TSHZ3 NACA PER1 POU2F1 CHD3 WDR5 BCOR ZHX2 IFI16 CREBBP ZNF503 ZNF469 TAF9B NFIX TLE4 TET1 ZFHX3 MYOCD ASXL2 MAGEC1 MUC1 ST18 LCOR | 3.20e-06 | 1399 | 151 | 27 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX6 TPR MAF1 KLF8 TSHZ3 NACA PER1 POU2F1 CHD3 WDR5 BCOR ZHX2 IFI16 CREBBP ZNF503 ZNF469 TAF9B NFIX TLE4 TET1 ZFHX3 MYOCD ASXL2 MAGEC1 MUC1 ST18 LCOR | 3.86e-06 | 1413 | 151 | 27 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | SOX6 TPR KLF8 NACA PER1 CHD3 WDR5 BCOR ZHX2 IFI16 CREBBP ZNF469 TAF9B NFIX TLE4 TET1 ZFHX3 MYOCD ASXL2 MAGEC1 ST18 LCOR | 8.67e-06 | 1053 | 151 | 22 | GO:0000122 |
| GeneOntologyCellularComponent | Golgi lumen | 9.72e-08 | 109 | 151 | 9 | GO:0005796 | |
| GeneOntologyCellularComponent | postsynaptic specialization | TANC2 MAP1A PCLO PSD3 TSC2 PDLIM5 USP6 RGS14 SNAP91 ARHGAP44 BSN CAP2 GABRA3 | 7.60e-05 | 503 | 151 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | MLL3/4 complex | 7.75e-05 | 12 | 151 | 3 | GO:0044666 | |
| GeneOntologyCellularComponent | postsynaptic density | TANC2 MAP1A PCLO PSD3 TSC2 PDLIM5 USP6 RGS14 SNAP91 ARHGAP44 BSN CAP2 | 1.10e-04 | 451 | 151 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | TANC2 MAP1A PCLO PSD3 TSC2 PDLIM5 USP6 RGS14 SNAP91 ARHGAP44 BSN CAP2 | 1.85e-04 | 477 | 151 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TPR BCL9L POU2F1 CHD3 E2F5 WDR5 BCOR POLA2 CREBBP WAC IVNS1ABP KMT2C TAF9B TLE4 TET1 NFRKB MYOCD ASXL2 SRRM2 POM121B UTY MYBL2 | 3.71e-04 | 1377 | 151 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | neuron to neuron synapse | TANC2 MAP1A PCLO PSD3 TSC2 PDLIM5 USP6 RGS14 SNAP91 ARHGAP44 BSN CAP2 | 4.27e-04 | 523 | 151 | 12 | GO:0098984 |
| Domain | SEA | 8.47e-07 | 23 | 147 | 5 | PS50024 | |
| Domain | SEA_dom | 8.47e-07 | 23 | 147 | 5 | IPR000082 | |
| Domain | SEA | 3.47e-06 | 14 | 147 | 4 | SM00200 | |
| Domain | SEA | 2.41e-05 | 22 | 147 | 4 | PF01390 | |
| Domain | TMEM183 | 6.15e-05 | 2 | 147 | 2 | IPR026509 | |
| Domain | SM_dom_ATX | 6.15e-05 | 2 | 147 | 2 | IPR025852 | |
| Domain | LsmAD | 6.15e-05 | 2 | 147 | 2 | PF06741 | |
| Domain | LsmAD_domain | 6.15e-05 | 2 | 147 | 2 | IPR009604 | |
| Domain | LsmAD | 6.15e-05 | 2 | 147 | 2 | SM01272 | |
| Domain | Znf_piccolo | 6.15e-05 | 2 | 147 | 2 | IPR008899 | |
| Domain | zf-piccolo | 6.15e-05 | 2 | 147 | 2 | PF05715 | |
| Domain | SM-ATX | 6.15e-05 | 2 | 147 | 2 | PF14438 | |
| Domain | BAT2_N | 1.84e-04 | 3 | 147 | 2 | PF07001 | |
| Domain | BAT2_N | 1.84e-04 | 3 | 147 | 2 | IPR009738 | |
| Domain | PRRC2 | 1.84e-04 | 3 | 147 | 2 | IPR033184 | |
| Domain | - | 2.03e-04 | 15 | 147 | 3 | 3.30.70.960 | |
| Domain | VWF_type-D | 2.48e-04 | 16 | 147 | 3 | IPR001846 | |
| Domain | VWFD | 2.48e-04 | 16 | 147 | 3 | PS51233 | |
| Domain | VWD | 2.48e-04 | 16 | 147 | 3 | SM00216 | |
| Domain | VWD | 2.48e-04 | 16 | 147 | 3 | PF00094 | |
| Domain | DCX | 9.04e-04 | 6 | 147 | 2 | SM00537 | |
| Domain | - | 1.26e-03 | 7 | 147 | 2 | 3.10.20.230 | |
| Domain | CTP_transf_like | 1.26e-03 | 7 | 147 | 2 | PF01467 | |
| Domain | Cyt_trans-like | 1.26e-03 | 7 | 147 | 2 | IPR004821 | |
| Domain | DCX | 1.26e-03 | 7 | 147 | 2 | PF03607 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.79e-16 | 16 | 101 | 9 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 8.01e-16 | 17 | 101 | 9 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.60e-14 | 23 | 101 | 9 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 9.77e-14 | 26 | 101 | 9 | M27483 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 8.41e-11 | 21 | 101 | 7 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 5.13e-10 | 62 | 101 | 9 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.20e-09 | 68 | 101 | 9 | M27303 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 6.02e-08 | 140 | 101 | 10 | M27484 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.57e-08 | 111 | 101 | 9 | M27416 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.22e-07 | 60 | 101 | 7 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 8.36e-07 | 143 | 101 | 9 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.29e-05 | 109 | 101 | 7 | MM15164 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 7.59e-05 | 250 | 101 | 9 | M27554 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | TPR MUC15 KBTBD8 MUC16 MUC5B CHD3 WDR5 MUC12 CHGB F5 CREBBP WAC TAF9B MAVS MUC17 CNTN5 MDC1 NFRKB ASXL2 MUC1 MUC3A MUC4 MUC6 | 2.46e-04 | 1475 | 101 | 23 | M19806 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 ATXN2L UBAP2 ARHGEF28 GPBP1 TRPM7 TEX2 CARMIL1 HJURP PSD3 TSC2 C6orf132 CEP350 IVNS1ABP USP31 RBSN MTUS1 ANLN PRRC2C TET1 DCLK2 PEAK1 SRRM2 CAMSAP2 ARHGAP21 WNK4 PHLDB2 DOP1B DYRK2 | 1.35e-17 | 861 | 153 | 29 | 36931259 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.29e-17 | 18 | 153 | 9 | 18834073 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L TSHZ3 POU2F1 WDR5 BCOR ZHX2 CREBBP EMSY ZNF503 KMT2C TLE4 MDC1 TET1 NFRKB ZFHX3 ASXL2 PRRC2B | 3.53e-13 | 351 | 153 | 17 | 38297188 |
| Pubmed | SOX6 BCL9L KLF8 TSHZ3 UBAP2 RRP1B NACA POU2F1 CHD3 SPAG9 WDR5 BCOR ZHX2 CREBBP EMSY ZNF503 KMT2C TAF9B ATXN2 PRRC2C NFIX TLE4 MDC1 NFRKB ZFHX3 ASXL2 SRRM2 PACSIN2 PRRC2B MYBL2 | 9.07e-13 | 1429 | 153 | 30 | 35140242 | |
| Pubmed | BCL9L CHD3 WDR5 BCOR CREBBP EMSY WAC TAF9B ANLN NFIX TLE4 MDC1 NFRKB PRRC2B | 1.71e-11 | 268 | 153 | 14 | 33640491 | |
| Pubmed | SPEG PSD3 ZHX2 USP31 PRRC2C TLE4 ASXL2 ANKRD12 CAMTA1 SRRM2 CAMSAP2 ST18 ARHGAP21 PRRC2B DOP1B PDZD2 | 4.10e-11 | 407 | 153 | 16 | 12693553 | |
| Pubmed | TPR TMEM183A TEX2 HJURP KBTBD8 CGB7 TMEM183BP CHD3 BCOR DCX KMT2C PAPOLA ANLN FMN1 TLE4 TET1 NFRKB ASXL2 ANKRD12 PEAK1 CAMTA1 TNS1 ARHGAP21 PACSIN2 | 7.80e-11 | 1084 | 153 | 24 | 11544199 | |
| Pubmed | UBAP2 RRP1B TEX2 VPS50 NACA AGAP11 BCOR CTTNBP2NL IVNS1ABP KMT2C UBXN4 MTUS1 MDC1 TET1 BSN LCOR CRAMP1 | 2.22e-10 | 529 | 153 | 17 | 14621295 | |
| Pubmed | TPR ATXN2L UBAP2 SPAG9 BCOR CREBBP EMSY PDLIM5 KMT2C TAF9B ANLN PRRC2C MDC1 TET1 NFRKB PEAK1 PRRC2B | 3.91e-10 | 549 | 153 | 17 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR ATXN2L CARMIL1 POU2F1 CHD3 SPAG9 BCOR POLA2 IFI16 CTTNBP2NL EMSY PAPOLA ANLN TLE4 MDC1 NFRKB SRRM2 PHLDB2 MYBL2 | 1.63e-09 | 774 | 153 | 19 | 15302935 |
| Pubmed | TPR ATXN2L PCYT1A RRP1B POLA2 IFI16 CTTNBP2NL WAC RBSN C18orf21 MAVS ANLN MTM1 SRRM2 PHLDB2 | 7.36e-09 | 503 | 153 | 15 | 16964243 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ATXN2L UBAP2 MAP1A CARMIL1 NACA CHD3 SPAG9 BCOR EMSY PDLIM5 WAC FAM193A MAVS PAPOLA PRRC2C CAMSAP2 ARHGAP21 PRRC2B | 3.33e-08 | 934 | 153 | 19 | 33916271 |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 23053434 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 27483328 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 24939955 | ||
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 23446997 | ||
| Pubmed | Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone. | 8.35e-08 | 3 | 153 | 3 | 17592322 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 35879412 | ||
| Pubmed | ATXN2L POU2F1 CHD3 BCOR IFI16 CREBBP EMSY WAC ZNF503 THAP4 KMT2C ATXN2 ANLN PRRC2C NFRKB ASXL2 SRRM2 LCOR PRRC2B MYBL2 | 9.17e-08 | 1103 | 153 | 20 | 34189442 | |
| Pubmed | TANC2 TPR ATXN2L BCL9L UBAP2 MAP1A TEX2 PCLO NACA PSD3 PER1 WDR5 RBSN UBXN4 PRRC2C DCLK2 PEAK1 BSN PYCR2 CAMSAP2 | 1.53e-07 | 1139 | 153 | 20 | 36417873 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KLF8 CARMIL1 BLNK GPATCH2 TMEM183BP CHD3 ZHX2 CREBBP HIVEP3 THAP4 KMT2C GUCY1A1 ATXN2 NFIX ARHGAP44 ZFHX3 DCLK2 ANKRD12 CAMTA1 LCOR CRAMP1 CAP2 PDZD2 | 1.64e-07 | 1489 | 153 | 23 | 28611215 |
| Pubmed | ATXN2L UBAP2 TEX2 VPS50 NACA PDLIM5 ZNF503 CEP350 UBXN4 FAM193A MAVS ANLN MDC1 NFRKB PACSIN2 MYBL2 | 1.70e-07 | 733 | 153 | 16 | 34672954 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TSHZ3 PCLO BCOR ZHX2 CREBBP ZNF503 KMT2C ANLN NFIX NFRKB LCOR PACSIN2 | 2.22e-07 | 398 | 153 | 12 | 35016035 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TPR ATXN2L UBAP2 RRP1B CHD3 BCOR EMSY WAC TAF9B SNAP91 ATXN2 ANLN PRRC2C MDC1 NFRKB SRRM2 LCOR MYBL2 | 2.38e-07 | 954 | 153 | 18 | 36373674 |
| Pubmed | TANC2 TPR UBAP2 TSC2 BCOR DCX EMSY SNAP91 ATXN2 PRRC2C ARHGAP44 BSN CAMSAP2 TNS1 ARHGAP21 CAP2 PRRC2B PHLDB2 | 2.73e-07 | 963 | 153 | 18 | 28671696 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | HJURP CHD3 E2F5 WDR5 BCOR ZNF503 KMT2C MTUS1 TET1 NFRKB ASXL2 LCOR MYBL2 | 3.30e-07 | 495 | 153 | 13 | 27705803 |
| Pubmed | TRPV4 activation in human corneal epithelial cells promotes membrane mucin production. | 3.33e-07 | 4 | 153 | 3 | 39024979 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 21596555 | ||
| Pubmed | Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. | 3.33e-07 | 4 | 153 | 3 | 18198997 | |
| Pubmed | MAP1A TEX2 CTTNBP2NL CEP350 FAM193A MTUS1 PEAK1 CAMSAP2 ARHGAP21 | 4.06e-07 | 209 | 153 | 9 | 36779422 | |
| Pubmed | TANC2 ATXN2L MAP1A RASGRF1 TEX2 PCLO SNAP91 BSN SRRM2 CAP2 GABRA3 | 4.40e-07 | 347 | 153 | 11 | 17114649 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TSHZ3 UBAP2 MAP1A HJURP C6orf132 ZNF469 FAM193A ATXN2 MDC1 CAMTA1 BSN WNK4 | 5.03e-07 | 430 | 153 | 12 | 35044719 |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 8.29e-07 | 5 | 153 | 3 | 11062147 | |
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 8.29e-07 | 5 | 153 | 3 | 16475027 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 18035521 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 9.36e-07 | 231 | 153 | 9 | 16452087 | |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 1.20e-06 | 77 | 153 | 6 | 24927568 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L UBAP2 CARMIL1 EVPL PDLIM5 C6orf132 MAVS ANLN FMN1 PEAK1 ARHGAP21 PACSIN2 PHLDB2 | 1.44e-06 | 565 | 153 | 13 | 25468996 |
| Pubmed | TET1 regulates hypoxia-induced epithelial-mesenchymal transition by acting as a co-activator. | 1.65e-06 | 6 | 153 | 3 | 25517638 | |
| Pubmed | 1.65e-06 | 6 | 153 | 3 | 19110483 | ||
| Pubmed | Identification of a novel interaction of 14-3-3 with p190RhoGEF. | 1.65e-06 | 6 | 153 | 3 | 11533041 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.70e-06 | 184 | 153 | 8 | 32908313 | |
| Pubmed | TPR ATXN2L UBAP2 BCOR ZHX2 PDLIM5 ZNF503 ATXN2 PRRC2C MDC1 SRRM2 | 1.72e-06 | 399 | 153 | 11 | 35987950 | |
| Pubmed | TPR MAP1A EVPL MUC12 CREBBP CEP350 KMT2C ERRFI1 MUC1 TNS1 PACSIN2 CAP2 | 1.80e-06 | 486 | 153 | 12 | 20936779 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | PCYT1A TSHZ3 RRP1B POU2F1 CHD3 WDR5 BCOR POLA2 EMSY ANLN MDC1 NFRKB MYBL2 | 3.22e-06 | 608 | 153 | 13 | 36089195 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MAP1A SPAG9 BCOR ZHX2 IFI16 CREBBP CTTNBP2NL EMSY MAVS ANLN NFRKB | 4.77e-06 | 444 | 153 | 11 | 34795231 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | KLF8 TEX2 AGAP11 POLA2 USP6 TET1 ZFHX3 PEAK1 CAMTA1 LCOR PACSIN2 MYBL2 | 4.91e-06 | 536 | 153 | 12 | 15840001 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.94e-06 | 283 | 153 | 9 | 30585729 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | TANC2 RRP1B CREBBP EMSY MTUS1 ANLN PEAK1 SRRM2 CAMSAP2 ARHGAP21 | 4.95e-06 | 361 | 153 | 10 | 30344098 |
| Pubmed | KLF8 TEX2 AGAP11 POLA2 USP6 TET1 ZFHX3 PEAK1 CAMTA1 LCOR PACSIN2 MYBL2 | 5.10e-06 | 538 | 153 | 12 | 10512203 | |
| Pubmed | TANC2 ATXN2L MAP1A CARMIL1 PCLO PSD3 CHD3 PDLIM5 USP31 SNAP91 PRRC2C ARHGAP44 DCLK2 PEAK1 BSN PYCR2 CAMSAP2 TNS1 ARHGAP21 PRRC2B | 5.12e-06 | 1431 | 153 | 20 | 37142655 | |
| Pubmed | 6.28e-06 | 371 | 153 | 10 | 15747579 | ||
| Pubmed | 6.93e-06 | 60 | 153 | 5 | 35175194 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | ATXN2L TMEM183A PCLO TMEM183BP WDR5 FAM193A ATXN2 PRRC2C WNK4 PRRC2B DYRK2 | 6.94e-06 | 462 | 153 | 11 | 31138677 |
| Pubmed | 8.23e-06 | 107 | 153 | 6 | 11347906 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 ATXN2L TEX2 PSD3 F5 FAM193A ATXN2 FMN1 PRRC2C NFRKB PRRC2B | 9.00e-06 | 475 | 153 | 11 | 31040226 |
| Pubmed | TANC2 MAP1A VPS50 GPATCH2 PER1 CHD3 BCOR CREBBP ZNF469 TAF9B MTUS1 NFRKB ZFHX3 SRRM2 LCOR PRRC2B PHLDB2 | 9.21e-06 | 1116 | 153 | 17 | 31753913 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX6 KLF8 TSHZ3 POU2F1 E2F5 ZHX2 HIVEP3 THAP4 NFIX ZFHX3 CAMTA1 ST18 LCOR CRAMP1 MYBL2 | 1.25e-05 | 908 | 153 | 15 | 19274049 |
| Pubmed | 1.27e-05 | 242 | 153 | 8 | 34011540 | ||
| Pubmed | TANC2 ARHGEF28 COL27A1 PER1 SPAG9 WAC CEP350 HIVEP3 CEP68 PEAK1 POM121B | 1.27e-05 | 493 | 153 | 11 | 15368895 | |
| Pubmed | RRP1B PSD3 SPAG9 BCOR CEP350 USP31 UBXN4 MTUS1 ATXN2 MTM1 PEAK1 PYCR2 SRRM2 TNS1 CAP2 PRRC2B | 1.69e-05 | 1049 | 153 | 16 | 27880917 | |
| Pubmed | ATXN2L WDR5 BCOR ZHX2 PDLIM5 WAC CEP350 USP6 ATXN2 PYCR2 CAMSAP2 PRRC2B | 1.73e-05 | 608 | 153 | 12 | 16713569 | |
| Pubmed | 1.76e-05 | 418 | 153 | 10 | 34709266 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.83e-05 | 123 | 153 | 6 | 26912792 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 10480912 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 1.92e-05 | 2 | 153 | 2 | 23403927 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 23883486 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 16194893 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 28885228 | ||
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 1.92e-05 | 2 | 153 | 2 | 26793095 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 38637838 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 20332206 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 30011875 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 19342486 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 17671696 | ||
| Pubmed | Active zone density is conserved during synaptic growth but impaired in aged mice. | 1.92e-05 | 2 | 153 | 2 | 21935939 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 25531720 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 20598042 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 27003157 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24039759 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 27283771 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 25087613 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 23687433 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 23544943 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 19236510 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 32604168 | ||
| Pubmed | Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. | 1.92e-05 | 2 | 153 | 2 | 8896555 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 14690056 | ||
| Pubmed | Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer. | 1.92e-05 | 2 | 153 | 2 | 24879526 | |
| Pubmed | Synaptic activity controls localization and function of CtBP1 via binding to Bassoon and Piccolo. | 1.92e-05 | 2 | 153 | 2 | 25652077 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24698420 | ||
| Pubmed | Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival. | 1.92e-05 | 2 | 153 | 2 | 24551091 | |
| Pubmed | Origination and evolution of a human-specific transmembrane protein gene, c1orf37-dup. | 1.92e-05 | 2 | 153 | 2 | 16644869 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 11285225 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 21615302 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 23925696 | ||
| Pubmed | Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis. | 1.92e-05 | 2 | 153 | 2 | 26246541 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24671186 | ||
| Pubmed | Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge. | 1.92e-05 | 2 | 153 | 2 | 27327081 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 15897748 | ||
| Interaction | YWHAH interactions | TANC2 ATXN2L UBAP2 ARHGEF28 GPBP1 TRPM7 TEX2 SPEG CARMIL1 HJURP PSD3 TSC2 POLA2 CREBBP C6orf132 CEP350 IVNS1ABP USP31 RBSN MTUS1 ANLN PRRC2C MTM1 TET1 ERRFI1 DCLK2 PEAK1 SRRM2 CAMSAP2 ARHGAP21 PHLDB2 DOP1B | 1.98e-11 | 1102 | 149 | 32 | int:YWHAH |
| Interaction | FEV interactions | POU2F1 BCOR ZHX2 CREBBP EMSY ZNF503 KMT2C TAF9B TLE4 NFRKB ZFHX3 ASXL2 PRRC2B MYBL2 | 3.48e-10 | 203 | 149 | 14 | int:FEV |
| Interaction | TLE3 interactions | SOX6 BCL9L TSHZ3 WDR5 BCOR CREBBP EMSY WAC ZNF503 FAM193A NFIX TLE4 NFRKB ZFHX3 ASXL2 SRRM2 LCOR MYBL2 | 3.80e-10 | 376 | 149 | 18 | int:TLE3 |
| Interaction | YWHAQ interactions | TANC2 TPR ATXN2L UBAP2 ARHGEF28 GPBP1 TRPM7 SPEG HJURP PSD3 TSC2 SPAG9 ZHX2 IFI16 C6orf132 CEP350 IVNS1ABP USP31 MTUS1 ANLN TET1 ERRFI1 DCLK2 PEAK1 CAMSAP2 ARHGAP21 WNK4 PHLDB2 | 1.16e-08 | 1118 | 149 | 28 | int:YWHAQ |
| Interaction | SOX6 interactions | SOX6 TSHZ3 RRP1B POU2F1 CHD3 BCOR ZHX2 ZNF503 PRRC2C NFIX ZFHX3 | 2.47e-08 | 157 | 149 | 11 | int:SOX6 |
| Interaction | PAX7 interactions | 2.86e-08 | 124 | 149 | 10 | int:PAX7 | |
| Interaction | SOX5 interactions | SOX6 KLF8 TSHZ3 POU2F1 CHD3 BCOR ZHX2 ZNF503 PRRC2C NFIX ZFHX3 | 3.42e-08 | 162 | 149 | 11 | int:SOX5 |
| Interaction | SFN interactions | TANC2 ATXN2L ARHGEF28 GPBP1 MAP1A TRPM7 TEX2 CARMIL1 TSC2 C6orf132 CEP350 USP31 MTUS1 ANLN PRRC2C ERRFI1 PEAK1 SRRM2 CAMSAP2 ARHGAP21 PHLDB2 | 4.12e-08 | 692 | 149 | 21 | int:SFN |
| Interaction | PAX6 interactions | TSHZ3 POU2F1 CHD3 BCOR ZHX2 CREBBP ZNF503 KMT2C NFIX TLE4 NFRKB ZFHX3 ASXL2 PRRC2B MYBL2 | 9.35e-08 | 366 | 149 | 15 | int:PAX6 |
| Interaction | NUP43 interactions | BCL9L RRP1B CHD3 WDR5 BCOR ZHX2 IFI16 EMSY TAF9B MAVS PRRC2C MDC1 NFRKB ZFHX3 ASXL2 SRRM2 LCOR MYBL2 PDZD2 | 1.88e-07 | 625 | 149 | 19 | int:NUP43 |
| Interaction | YWHAZ interactions | TANC2 ATXN2L ARHGEF28 GPBP1 RASGRF1 TRPM7 TEX2 SPEG HJURP PSD3 TSC2 WDR5 BCOR ZHX2 IFI16 C6orf132 IVNS1ABP USP31 MTUS1 ANLN MDC1 ERRFI1 ASXL2 PEAK1 CAMSAP2 TNS1 ARHGAP21 PHLDB2 | 3.69e-07 | 1319 | 149 | 28 | int:YWHAZ |
| Interaction | EGR2 interactions | 5.88e-07 | 171 | 149 | 10 | int:EGR2 | |
| Interaction | YWHAG interactions | TANC2 ATXN2L UBAP2 ARHGEF28 GPBP1 TRPM7 SPEG CARMIL1 HJURP PSD3 TSC2 IFI16 C6orf132 CEP350 USP31 MTUS1 ANLN PRRC2C TET1 ERRFI1 DCLK2 PEAK1 SRRM2 CAMSAP2 ARHGAP21 PHLDB2 | 1.46e-06 | 1248 | 149 | 26 | int:YWHAG |
| Interaction | YWHAE interactions | TANC2 ATXN2L ARHGEF28 GPBP1 RASGRF1 TRPM7 HJURP PSD3 TSC2 DCX C6orf132 IVNS1ABP USP31 PAPOLA ANLN TET1 ERRFI1 DCLK2 ASXL2 PEAK1 SRRM2 CAMSAP2 LCOR ARHGAP21 CAP2 PHLDB2 | 1.65e-06 | 1256 | 149 | 26 | int:YWHAE |
| Interaction | SP7 interactions | BCL9L TSHZ3 POU2F1 CHD3 BCOR CREBBP ZNF503 KMT2C NFIX TLE4 PRRC2B MYBL2 | 2.81e-06 | 304 | 149 | 12 | int:SP7 |
| Interaction | BAG2 interactions | UBAP2 TEX2 HJURP POU2F1 BCOR CREBBP PDLIM5 ZNF503 MAVS PAPOLA ANLN PRRC2C TLE4 MDC1 NFRKB SRRM2 ARHGAP21 | 3.67e-06 | 622 | 149 | 17 | int:BAG2 |
| Interaction | GSC interactions | 3.74e-06 | 87 | 149 | 7 | int:GSC | |
| Interaction | AR interactions | TPR BCL9L BLNK POU2F1 CHD3 WDR5 BCOR IFI16 CREBBP EMSY WAC KMT2C TAF9B ANLN NFIX TLE4 MDC1 NFRKB ZFHX3 TNS1 LCOR PRRC2B | 3.89e-06 | 992 | 149 | 22 | int:AR |
| Interaction | YWHAB interactions | TANC2 ATXN2L ARHGEF28 RASGRF1 TRPM7 SPEG HJURP PSD3 TSC2 PDLIM5 C6orf132 CEP350 IVNS1ABP USP31 ANLN ERRFI1 DCLK2 PEAK1 SRRM2 CAMSAP2 ARHGAP21 PHLDB2 | 5.52e-06 | 1014 | 149 | 22 | int:YWHAB |
| Interaction | PAX9 interactions | 5.61e-06 | 130 | 149 | 8 | int:PAX9 | |
| Interaction | GSK3B interactions | MAP1A RRP1B TEX2 NACA TSC2 CHD3 WDR5 CTTNBP2NL CEP350 CABYR FAM193A MTUS1 PRRC2C MYOCD PEAK1 MUC1 CAMSAP2 ARHGAP21 PACSIN2 DYRK2 | 6.40e-06 | 868 | 149 | 20 | int:GSK3B |
| Interaction | HNF4A interactions | CHD3 WDR5 BCOR ZHX2 CREBBP EMSY KMT2C TAF9B NFRKB ASXL2 MYBL2 | 6.54e-06 | 275 | 149 | 11 | int:HNF4A |
| Interaction | NFIX interactions | 7.52e-06 | 227 | 149 | 10 | int:NFIX | |
| Interaction | FMR1 interactions | ATXN2L UBAP2 CHD3 IFI16 EMSY TAF9B ATXN2 ANLN PRRC2C TLE4 BSN CAMSAP2 TNS1 ARHGAP21 PRRC2B | 1.07e-05 | 536 | 149 | 15 | int:FMR1 |
| Interaction | TLX3 interactions | BCL9L PER1 POU2F1 WDR5 BCOR ZNF503 KMT2C NFIX TLE4 ZFHX3 ITIH6 | 1.11e-05 | 291 | 149 | 11 | int:TLX3 |
| Interaction | CEBPA interactions | ATXN2L RASGRF1 RRP1B POU2F1 CHD3 WDR5 BCOR IFI16 CREBBP EMSY WAC ZNF503 THAP4 KMT2C ATXN2 ANLN PRRC2C NFRKB ASXL2 PYCR2 SRRM2 LCOR PRRC2B MYBL2 | 1.45e-05 | 1245 | 149 | 24 | int:CEBPA |
| Interaction | TBR1 interactions | 2.10e-05 | 113 | 149 | 7 | int:TBR1 | |
| Interaction | ELF2 interactions | 2.13e-05 | 156 | 149 | 8 | int:ELF2 | |
| Interaction | RBBP4 interactions | TSHZ3 HJURP CHD3 SPAG9 WDR5 BCOR ZHX2 IFI16 CREBBP EMSY ANLN ASXL2 SRRM2 LCOR MYBL2 | 2.34e-05 | 573 | 149 | 15 | int:RBBP4 |
| Interaction | G3BP2 interactions | TPR ATXN2L KLF8 UBAP2 RRP1B WDR5 IFI16 IVNS1ABP RGS14 ATXN2 ANLN PRRC2C PRRC2B DYRK2 | 3.14e-05 | 518 | 149 | 14 | int:G3BP2 |
| Interaction | KLF8 interactions | KLF8 POU2F1 BCOR ZHX2 CREBBP EMSY TAF9B PRRC2C NFRKB PRRC2B MYBL2 | 3.46e-05 | 329 | 149 | 11 | int:KLF8 |
| Interaction | HDAC4 interactions | TANC2 TPR ATXN2L TEX2 PSD3 BCOR PDLIM5 FAM193A ATXN2 FMN1 PRRC2C NFRKB MYOCD CAMSAP2 LCOR PRRC2B PHLDB2 | 3.71e-05 | 744 | 149 | 17 | int:HDAC4 |
| Interaction | FOXK2 interactions | 4.63e-05 | 225 | 149 | 9 | int:FOXK2 | |
| Interaction | CTBP1 interactions | SOX6 KLF8 TSHZ3 PCLO CHD3 BCOR CREBBP CEP68 MDC1 SRRM2 LCOR PRRC2B | 5.04e-05 | 406 | 149 | 12 | int:CTBP1 |
| Interaction | TEAD1 interactions | 5.05e-05 | 176 | 149 | 8 | int:TEAD1 | |
| Interaction | KLF3 interactions | 5.13e-05 | 228 | 149 | 9 | int:KLF3 | |
| Interaction | GATAD1 interactions | 5.44e-05 | 131 | 149 | 7 | int:GATAD1 | |
| Interaction | KLF15 interactions | TSHZ3 RRP1B BCOR CREBBP EMSY KMT2C PRRC2C NFRKB PRRC2B MYBL2 | 6.13e-05 | 290 | 149 | 10 | int:KLF15 |
| Interaction | TERF2IP interactions | PCYT1A CHD3 WDR5 BCOR POLA2 CREBBP EMSY TAF9B ANLN MDC1 NFRKB SRRM2 PACSIN2 MYBL2 | 6.24e-05 | 552 | 149 | 14 | int:TERF2IP |
| Interaction | FOXI1 interactions | 6.24e-05 | 92 | 149 | 6 | int:FOXI1 | |
| Interaction | HDAC1 interactions | SOX6 TPR TSHZ3 TRPM7 POU2F1 CHD3 SPAG9 WDR5 BCOR ZHX2 CREBBP EMSY PDLIM5 PAPOLA ANLN NFIX TLE4 TET1 ZFHX3 LCOR ARHGAP21 | 6.73e-05 | 1108 | 149 | 21 | int:HDAC1 |
| Interaction | NUP35 interactions | BCL9L BCOR IFI16 CREBBP ZNF503 HIVEP3 KMT2C MAVS ATXN2 PRRC2C PRRC2B PDZD2 | 7.62e-05 | 424 | 149 | 12 | int:NUP35 |
| Interaction | SNRNP40 interactions | BCL9L RRP1B CHD3 WDR5 BCOR ZHX2 EMSY WAC TAF9B ANLN MDC1 NFRKB ZFHX3 SRRM2 MYBL2 | 7.80e-05 | 637 | 149 | 15 | int:SNRNP40 |
| Interaction | HNF1B interactions | 8.64e-05 | 190 | 149 | 8 | int:HNF1B | |
| Interaction | TLX2 interactions | 9.06e-05 | 142 | 149 | 7 | int:TLX2 | |
| Interaction | CBX3 interactions | CHD3 WDR5 BCOR IFI16 PDLIM5 WAC TAF9B ANLN MDC1 NFRKB ASXL2 SRRM2 LCOR PRRC2B MYBL2 | 9.12e-05 | 646 | 149 | 15 | int:CBX3 |
| Interaction | SYNGAP1 interactions | TANC2 ATXN2L MAP1A PDLIM5 RGS14 RBSN PEAK1 CAMSAP2 LCOR ARHGAP21 | 9.83e-05 | 307 | 149 | 10 | int:SYNGAP1 |
| Interaction | PFN1 interactions | TPR MAP1A TEX2 CARMIL1 PCLO CTTNBP2NL PDLIM5 C6orf132 CEP350 ANLN PEAK1 ARHGAP21 DOP1B | 1.07e-04 | 509 | 149 | 13 | int:PFN1 |
| Interaction | NAA40 interactions | TPR ATXN2L UBAP2 MAP1A CARMIL1 NACA CHD3 SPAG9 BCOR EMSY PDLIM5 WAC FAM193A MAVS PAPOLA PRRC2C CAMSAP2 ARHGAP21 PRRC2B | 1.12e-04 | 978 | 149 | 19 | int:NAA40 |
| Interaction | POU5F1 interactions | TPR NACA MUC16 TSC2 CHD3 WDR5 POLA2 ZNF865 EMSY MDC1 TET1 NFRKB ZFHX3 PRRC2B | 1.13e-04 | 584 | 149 | 14 | int:POU5F1 |
| Interaction | CRX interactions | 1.17e-04 | 254 | 149 | 9 | int:CRX | |
| Interaction | GATA2 interactions | 1.19e-04 | 199 | 149 | 8 | int:GATA2 | |
| Interaction | SH3KBP1 interactions | CARMIL1 BLNK IVNS1ABP PAPOLA ATXN2 ANLN ARHGAP44 MDC1 SRRM2 PHLDB2 | 1.21e-04 | 315 | 149 | 10 | int:SH3KBP1 |
| Interaction | H3-3A interactions | PCYT1A TSHZ3 RRP1B POU2F1 CHD3 SPAG9 WDR5 BCOR POLA2 CREBBP EMSY KMT2C ANLN MDC1 NFRKB MYBL2 | 1.39e-04 | 749 | 149 | 16 | int:H3-3A |
| Interaction | LSM14A interactions | 1.40e-04 | 260 | 149 | 9 | int:LSM14A | |
| Interaction | DPY30 interactions | 1.41e-04 | 204 | 149 | 8 | int:DPY30 | |
| Interaction | ACTB interactions | PCYT1A MAP1A CHD3 WDR5 IFI16 CREBBP CTTNBP2NL PDLIM5 C6orf132 IVNS1ABP THAP4 ATXN2 ANLN ERRFI1 NFRKB PEAK1 LCOR ARHGAP21 CAP2 PCYT1B | 1.45e-04 | 1083 | 149 | 20 | int:ACTB |
| Interaction | YY1 interactions | ATXN2L KLF8 CHD3 WDR5 ZHX2 CREBBP EMSY TAF9B NFIX MDC1 NFRKB ASXL2 | 1.45e-04 | 454 | 149 | 12 | int:YY1 |
| Interaction | GCM1 interactions | 1.48e-04 | 68 | 149 | 5 | int:GCM1 | |
| Interaction | TAF4 interactions | 1.63e-04 | 156 | 149 | 7 | int:TAF4 | |
| Interaction | PHF12 interactions | 1.68e-04 | 110 | 149 | 6 | int:PHF12 | |
| Interaction | NFIC interactions | 1.72e-04 | 210 | 149 | 8 | int:NFIC | |
| Interaction | PAX8 interactions | 1.77e-04 | 111 | 149 | 6 | int:PAX8 | |
| Interaction | GSK3A interactions | MAP1A RRP1B TEX2 CTTNBP2NL CEP350 FAM193A MTUS1 PEAK1 SRRM2 CAMSAP2 LCOR ARHGAP21 | 1.77e-04 | 464 | 149 | 12 | int:GSK3A |
| Interaction | ZC3H7A interactions | 2.02e-04 | 215 | 149 | 8 | int:ZC3H7A | |
| Interaction | MYBL2 interactions | 2.06e-04 | 162 | 149 | 7 | int:MYBL2 | |
| Interaction | CCAR2 interactions | 2.10e-04 | 337 | 149 | 10 | int:CCAR2 | |
| Interaction | EIF3B interactions | 2.10e-04 | 337 | 149 | 10 | int:EIF3B | |
| Interaction | USP7 interactions | SOX6 TPR UBAP2 PCARE WDR5 BCOR IFI16 CREBBP MAVS ANLN FAM186A TNFRSF8 MTM1 MDC1 KIAA1755 BSN SRRM2 LCOR UTY STAG3 PHLDB2 PCYT1B | 2.63e-04 | 1313 | 149 | 22 | int:USP7 |
| Interaction | KMT2D interactions | 2.66e-04 | 169 | 149 | 7 | int:KMT2D | |
| Interaction | CSNK2A2 interactions | MAF1 RRP1B NACA GPATCH2 WDR5 BCOR IFI16 CREBBP EMSY ANLN PRRC2C PYCR2 SRRM2 CAMSAP2 CAP2 | 2.87e-04 | 718 | 149 | 15 | int:CSNK2A2 |
| Interaction | RBBP5 interactions | 2.92e-04 | 287 | 149 | 9 | int:RBBP5 | |
| Interaction | WWTR1 interactions | ATXN2L UBAP2 SPAG9 BCOR CREBBP EMSY PDLIM5 ANLN PRRC2C PEAK1 PRRC2B | 3.10e-04 | 422 | 149 | 11 | int:WWTR1 |
| Interaction | PRRC2C interactions | 3.15e-04 | 290 | 149 | 9 | int:PRRC2C | |
| Interaction | CNOT9 interactions | 3.29e-04 | 231 | 149 | 8 | int:CNOT9 | |
| Interaction | KLF16 interactions | RRP1B POU2F1 WDR5 BCOR ZHX2 EMSY ZNF503 PRRC2C NFRKB PRRC2B MYBL2 | 3.29e-04 | 425 | 149 | 11 | int:KLF16 |
| Interaction | TLX1 interactions | 3.29e-04 | 175 | 149 | 7 | int:TLX1 | |
| Interaction | BRMS1L interactions | 3.36e-04 | 125 | 149 | 6 | int:BRMS1L | |
| Interaction | ELF1 interactions | 3.51e-04 | 126 | 149 | 6 | int:ELF1 | |
| Interaction | ANAPC2 interactions | 3.58e-04 | 234 | 149 | 8 | int:ANAPC2 | |
| Interaction | KRT2 interactions | 3.79e-04 | 236 | 149 | 8 | int:KRT2 | |
| Interaction | QPRT interactions | 3.99e-04 | 84 | 149 | 5 | int:QPRT | |
| Interaction | IRF9 interactions | 4.00e-04 | 47 | 149 | 4 | int:IRF9 | |
| Interaction | PIP interactions | 4.03e-04 | 181 | 149 | 7 | int:PIP | |
| Interaction | PAX2 interactions | 4.21e-04 | 85 | 149 | 5 | int:PAX2 | |
| Interaction | LHX2 interactions | 4.31e-04 | 183 | 149 | 7 | int:LHX2 | |
| Interaction | SMC5 interactions | TPR ATXN2L UBAP2 RRP1B CHD3 BCOR EMSY WAC TAF9B SNAP91 ATXN2 ANLN PRRC2C MDC1 NFRKB SRRM2 LCOR MYBL2 | 4.32e-04 | 1000 | 149 | 18 | int:SMC5 |
| Interaction | PYGO2 interactions | 4.34e-04 | 48 | 149 | 4 | int:PYGO2 | |
| Interaction | LHX3 interactions | 4.60e-04 | 185 | 149 | 7 | int:LHX3 | |
| Interaction | G3BP1 interactions | SOX6 ATXN2L KLF8 UBAP2 RRP1B CHD3 WDR5 IFI16 CTTNBP2NL PDLIM5 ATXN2 ANLN PRRC2C PYCR2 PRRC2B PHLDB2 | 4.67e-04 | 835 | 149 | 16 | int:G3BP1 |
| Interaction | RADX interactions | 4.70e-04 | 49 | 149 | 4 | int:RADX | |
| Interaction | ZBTB5 interactions | 4.70e-04 | 49 | 149 | 4 | int:ZBTB5 | |
| Interaction | PRPF40A interactions | TPR ATXN2L CHD3 IFI16 ANLN FMN1 ZFHX3 ASXL2 SRRM2 CAP2 PDZD2 | 4.93e-04 | 446 | 149 | 11 | int:PRPF40A |
| Interaction | CDC16 interactions | 4.99e-04 | 246 | 149 | 8 | int:CDC16 | |
| Interaction | YTHDF2 interactions | 5.35e-04 | 312 | 149 | 9 | int:YTHDF2 | |
| Interaction | ASF1A interactions | 5.41e-04 | 249 | 149 | 8 | int:ASF1A | |
| Interaction | LIN52 interactions | 5.47e-04 | 51 | 149 | 4 | int:LIN52 | |
| Interaction | TRIM56 interactions | 5.48e-04 | 137 | 149 | 6 | int:TRIM56 | |
| Interaction | ZHX1 interactions | 5.76e-04 | 91 | 149 | 5 | int:ZHX1 | |
| Interaction | GAPDH interactions | TSHZ3 ARHGEF28 POU2F1 TSC2 CHD3 WDR5 USP31 ATXN2 ANLN PRRC2C TET1 ZFHX3 ASXL2 ARHGAP21 | 5.80e-04 | 686 | 149 | 14 | int:GAPDH |
| Cytoband | 1q25.2 | 1.52e-04 | 31 | 153 | 3 | 1q25.2 | |
| GeneFamily | CD molecules|Mucins | 2.82e-16 | 21 | 88 | 9 | 648 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.86e-05 | 15 | 88 | 3 | 529 | |
| GeneFamily | Doublecortin superfamily | 1.03e-03 | 10 | 88 | 2 | 1369 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.19e-03 | 53 | 88 | 3 | 532 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.36e-03 | 15 | 88 | 2 | 26 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.33e-03 | 206 | 88 | 5 | 682 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | RRP1B PSD3 E2F5 ZHX2 CREBBP CEP350 USP6 HEG1 MTUS1 TLE4 MTM1 MDC1 DYRK2 | 2.18e-08 | 300 | 151 | 13 | M8702 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 SPEG PCLO POU2F1 FHOD3 TSC2 CHD3 DCX HIVEP3 SNAP91 MTUS1 GUCY1A1 NFIX CNTN5 ZFHX3 DCLK2 ANKRD12 CAMTA1 BSN CAMSAP2 PRRC2B DOP1B DYRK2 | 9.58e-08 | 1106 | 151 | 23 | M39071 |
| Coexpression | NABA_ECM_AFFILIATED | 6.59e-07 | 170 | 151 | 9 | M5880 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | TANC2 MAP1A PCLO TSC2 CHGB DCX IVNS1ABP SNAP91 GUCY1A1 ATXN2 NFIX DCLK2 CAP2 | 5.36e-06 | 488 | 151 | 13 | M39104 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 5.73e-06 | 221 | 151 | 9 | M39222 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | TANC2 TSHZ3 MAP1A RASGRF1 SPEG PCLO PSD3 WAC KMT2C UBXN4 SNAP91 ATXN2 ERRFI1 ANKRD12 ST18 TNS1 PRRC2B PDZD2 | 9.13e-06 | 946 | 151 | 18 | M39169 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PSD3 E2F5 SPAG9 ZHX2 CREBBP PDLIM5 CEP350 USP6 HEG1 FAM193A ATXN2 PRRC2C TLE4 ZFHX3 CAMSAP2 CAP2 DOP1B | 9.49e-06 | 856 | 151 | 17 | M4500 |
| Coexpression | GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP | 1.75e-05 | 194 | 151 | 8 | M4234 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN | 1.96e-05 | 197 | 151 | 8 | M9910 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 2.18e-05 | 200 | 151 | 8 | M3510 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP | 2.18e-05 | 200 | 151 | 8 | M6367 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 2.18e-05 | 200 | 151 | 8 | M7839 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.78e-05 | 158 | 151 | 7 | MM17063 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | MAP1A SPEG POU2F1 DCX PDLIM5 TLE4 ERRFI1 MYOCD IQCJ-SCHIP1 PACSIN2 CAP2 PHLDB2 DYRK2 | 3.87e-05 | 589 | 151 | 13 | M45662 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL | 5.03e-05 | 113 | 151 | 6 | M45793 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 MAP1A TEX2 SPEG COL27A1 VPS50 FHOD3 CHD3 WAC FAM193A TAF9B PRRC2C ZFHX3 ANKRD12 HERPUD2 CAMSAP2 TNS1 PHLDB2 | 6.78e-05 | 1102 | 151 | 18 | M2369 |
| Coexpression | GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP | 7.22e-05 | 175 | 151 | 7 | M8908 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZHX2 CREBBP CEP350 USP6 HEG1 ATXN2 PRRC2C TLE4 CAMSAP2 CAP2 DOP1B | 8.60e-05 | 466 | 151 | 11 | M13522 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 MAP1A TEX2 SPEG COL27A1 VPS50 FHOD3 CHD3 WAC FAM193A TAF9B PRRC2C ZFHX3 ANKRD12 HERPUD2 CAMSAP2 TNS1 PHLDB2 | 8.70e-05 | 1124 | 151 | 18 | MM1070 |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN | 1.33e-04 | 193 | 151 | 7 | M6903 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_UP | 1.42e-04 | 195 | 151 | 7 | M4936 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.56e-04 | 198 | 151 | 7 | M8624 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.60e-04 | 417 | 151 | 10 | M39224 | |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.61e-04 | 199 | 151 | 7 | M8606 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN | 1.61e-04 | 199 | 151 | 7 | M4964 | |
| Coexpression | GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN | 1.66e-04 | 200 | 151 | 7 | M8052 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP | 1.66e-04 | 200 | 151 | 7 | M5815 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP | 1.66e-04 | 200 | 151 | 7 | M7713 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 1.66e-04 | 200 | 151 | 7 | M9260 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.99e-04 | 145 | 151 | 6 | M1810 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | TPR SPEG DCX CEP350 USP31 FAM193A GUCY1A1 MYOCD ASXL2 CAMSAP2 PRRC2B GABRA3 | 2.16e-06 | 312 | 149 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | TPR MUC15 SPEG IFI16 DCX CTTNBP2NL CEP350 USP31 FAM193A GUCY1A1 NFIX MYOCD ASXL2 CAMTA1 CAMSAP2 CAP2 PRRC2B GABRA3 PDZD2 | 3.85e-06 | 806 | 149 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TANC2 TRPM7 MUC15 CHGB IFI16 DCX CREBBP PDLIM5 CEP350 USP31 SNAP91 PRRC2C MYOCD ASXL2 CAMSAP2 ST18 LCOR CAP2 GABRA3 | 4.76e-06 | 818 | 149 | 19 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | TPR MUC15 IFI16 DCX CTTNBP2NL CEP350 USP31 FAM193A NFIX MYOCD ASXL2 CAMSAP2 CAP2 | 6.18e-06 | 407 | 149 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 1.05e-05 | 149 | 149 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPR MUC15 CHGB IFI16 DCX CTTNBP2NL CEP350 USP31 FAM193A GUCY1A1 NFIX TLE4 MYOCD ASXL2 CAMSAP2 CAP2 GABRA3 PDZD2 | 1.47e-05 | 806 | 149 | 18 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | MAP1A CARMIL1 PCLO PSD3 CHD3 ZHX2 DCX HIVEP3 USP31 FMN1 NFIX TLE4 ANKRD12 PEAK1 ITIH6 MUC4 ST18 MUC6 CNTFR PCYT1B | 1.59e-05 | 973 | 149 | 20 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | TANC2 TRPM7 CREBBP PDLIM5 CEP350 USP31 MYOCD ASXL2 CAMSAP2 LCOR GABRA3 | 2.22e-05 | 330 | 149 | 11 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX6 TPR RRP1B TRPM7 VPS50 POU2F1 FHOD3 E2F5 EMSY WAC CEP350 HEG1 C18orf21 FAM193A PAPOLA ANLN TLE4 MDC1 TET1 ZFHX3 ARHGAP21 CNTFR MYBL2 | 2.24e-05 | 1257 | 149 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.30e-05 | 166 | 149 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | ARHGEF28 TRPM7 HJURP DCX PDLIM5 CEP350 UBXN4 PRRC2C ASXL2 CAMSAP2 LCOR | 2.84e-05 | 339 | 149 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | RASGRF1 KBTBD8 BLNK FHOD3 DCX CTTNBP2NL PDLIM5 CEP350 FAM193A PAPOLA PRRC2C MYOCD ASXL2 MUC1 CAMSAP2 LCOR WNK4 | 4.44e-05 | 795 | 149 | 17 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | TRPM7 HJURP CREBBP HIVEP3 KMT2C HEG1 PAPOLA GUCY1A1 ATXN2 PRRC2C NFIX TET1 ZFHX3 ANKRD12 TNS1 LCOR UTY | 4.87e-05 | 801 | 149 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | MUC15 CHGB IFI16 DCX PDLIM5 CEP350 USP31 SNAP91 MYOCD ASXL2 ST18 LCOR | 4.98e-05 | 427 | 149 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_100 | 5.29e-05 | 94 | 149 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 8.16e-05 | 255 | 149 | 9 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX6 TPR MAP1A RRP1B TRPM7 PSD3 FHOD3 SPAG9 CHGB BCOR DCX EMSY WAC HEG1 TAF9B SNAP91 TLE4 ARHGAP44 DCLK2 CAMTA1 ARHGAP21 GABRA3 MYBL2 | 8.43e-05 | 1370 | 149 | 23 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | HJURP KBTBD8 E2F5 CREBBP KMT2C HEG1 SNAP91 MTUS1 GUCY1A1 PRRC2C NFIX MTM1 ANKRD12 CAMTA1 LCOR MYBL2 | 1.05e-04 | 770 | 149 | 16 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | SOX6 TRPM7 BLNK GPATCH2 PDLIM5 C6orf132 CEP350 IVNS1ABP PAPOLA PRRC2C ASXL2 MUC1 CAMSAP2 LCOR WNK4 DOP1B | 1.12e-04 | 774 | 149 | 16 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | TANC2 GPBP1 TRPM7 HJURP PDLIM5 CEP350 USP31 MYOCD ASXL2 LCOR GABRA3 | 1.17e-04 | 397 | 149 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | PCYT1A TRPM7 HJURP CREBBP KMT2C HEG1 TAF9B GUCY1A1 PRRC2C MTM1 ASXL2 ANKRD12 PEAK1 CAMTA1 LCOR STAG3 | 1.18e-04 | 778 | 149 | 16 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | RASGRF1 KBTBD8 BLNK FHOD3 DCX CTTNBP2NL CEP350 PAPOLA PRRC2C MUC1 CAMSAP2 | 1.31e-04 | 402 | 149 | 11 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | TRPM7 HJURP CREBBP HEG1 ATXN2 PRRC2C NFIX TET1 MYOCD TNS1 LCOR | 1.42e-04 | 406 | 149 | 11 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 1.50e-04 | 162 | 149 | 7 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | SOX6 ARHGEF28 TRPM7 HJURP BLNK FHOD3 DCX PDLIM5 C6orf132 CEP350 UBXN4 PRRC2C ASXL2 MUC1 CAMSAP2 LCOR | 1.65e-04 | 801 | 149 | 16 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | MAP1A CARMIL1 PCLO USP31 TLE4 ANKRD12 ITIH6 MUC4 ST18 MUC6 CNTFR PCYT1B | 1.82e-04 | 490 | 149 | 12 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX6 TPR RRP1B TRPM7 VPS50 POU2F1 FHOD3 E2F5 EMSY WAC CEP350 HEG1 C18orf21 FAM193A PAPOLA ANLN TLE4 MDC1 TET1 ZFHX3 ARHGAP21 CNTFR MYBL2 | 2.14e-04 | 1459 | 149 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#4 | 3.02e-04 | 129 | 149 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | KBTBD8 DCX CEP350 FAM193A PAPOLA PRRC2C ASXL2 MUC1 CAMSAP2 LCOR | 3.54e-04 | 379 | 149 | 10 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | SOX6 TANC2 MAP1A PSD3 MUC16 GUCY1A1 ANLN NFIX MDC1 TET1 MYOCD PEAK1 TNS1 CNTFR PDZD2 | 3.82e-04 | 777 | 149 | 15 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 4.79e-04 | 92 | 149 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | TRPM7 COL27A1 HJURP CREBBP KMT2C HEG1 ATXN2 PRRC2C NFIX TET1 MYOCD ANKRD12 TNS1 LCOR UTY | 5.11e-04 | 799 | 149 | 15 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SOX6 TRPM7 HJURP CHGB CREBBP PAPOLA GUCY1A1 ATXN2 PRRC2C TET1 TNS1 LCOR UTY STAG3 MYBL2 | 5.59e-04 | 806 | 149 | 15 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.71e-04 | 202 | 149 | 7 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | TANC2 GPBP1 TRPM7 HJURP IFI16 PDLIM5 CEP350 USP31 ZNF469 NFIX MYOCD ASXL2 LCOR CAP2 GABRA3 | 5.95e-04 | 811 | 149 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.10e-04 | 97 | 149 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 6.28e-04 | 408 | 149 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TANC2 TPR MUC15 CHGB IFI16 DCX CEP350 USP31 FAM193A NFIX ZFHX3 MYOCD ASXL2 CAMSAP2 GABRA3 | 6.50e-04 | 818 | 149 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | TANC2 TEX2 VPS50 KBTBD8 WDR5 USP31 KMT2C TAF9B ANLN MDC1 TET1 DCLK2 ANKRD12 STAG3 MYBL2 | 6.67e-04 | 820 | 149 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.97e-04 | 151 | 149 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-08 | 176 | 152 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.07e-08 | 200 | 152 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.19e-07 | 168 | 152 | 8 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 177 | 152 | 8 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 177 | 152 | 8 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-07 | 191 | 152 | 8 | 54f07e4de61735051498846afb44b1798bed8144 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 4.01e-07 | 197 | 152 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 4.01e-07 | 197 | 152 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.33e-07 | 199 | 152 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.49e-07 | 200 | 152 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.83e-06 | 168 | 152 | 7 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.14e-06 | 172 | 152 | 7 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.35e-06 | 184 | 152 | 7 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.35e-06 | 184 | 152 | 7 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.60e-06 | 186 | 152 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 187 | 152 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.73e-06 | 187 | 152 | 7 | 218c9b4f28499389c43005d9626af2ac01066027 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.73e-06 | 187 | 152 | 7 | c7ac4b328efc2ebb72f71154661914193ff402ca | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.43e-06 | 192 | 152 | 7 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.59e-06 | 193 | 152 | 7 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.59e-06 | 193 | 152 | 7 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.59e-06 | 193 | 152 | 7 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 195 | 152 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 195 | 152 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-06 | 195 | 152 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-06 | 197 | 152 | 7 | 61b1b10a017cbeb17f8529fcae66cba77ee2f115 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.25e-06 | 197 | 152 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.25e-06 | 197 | 152 | 7 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.42e-06 | 198 | 152 | 7 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.61e-06 | 199 | 152 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 5.61e-06 | 199 | 152 | 7 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 5.61e-06 | 199 | 152 | 7 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.79e-06 | 200 | 152 | 7 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.79e-06 | 200 | 152 | 7 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.79e-06 | 200 | 152 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.79e-06 | 200 | 152 | 7 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.67e-05 | 157 | 152 | 6 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-05 | 162 | 152 | 6 | 80619a93c57fe16daf91dc571874ef9ac888953d | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 2.62e-05 | 170 | 152 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-05 | 170 | 152 | 6 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.71e-05 | 171 | 152 | 6 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 173 | 152 | 6 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.89e-05 | 173 | 152 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.89e-05 | 173 | 152 | 6 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.89e-05 | 173 | 152 | 6 | f31e738c2b3b319fb40b0b16b2393a51c9a8999c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-05 | 174 | 152 | 6 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-05 | 174 | 152 | 6 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.08e-05 | 175 | 152 | 6 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 176 | 152 | 6 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 176 | 152 | 6 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.39e-05 | 178 | 152 | 6 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 178 | 152 | 6 | f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 178 | 152 | 6 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 178 | 152 | 6 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.39e-05 | 178 | 152 | 6 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 179 | 152 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 179 | 152 | 6 | 142457c98656ed389461e081e0e6d03e86d2fb1a | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 3.50e-05 | 179 | 152 | 6 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.61e-05 | 180 | 152 | 6 | ce2fc270f9d9110c2544083f61936b0b7d3b7eb3 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.72e-05 | 181 | 152 | 6 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | (09)_Ionocytes-(3)_72hpi|(09)_Ionocytes / shred by cell type and Timepoint | 3.79e-05 | 110 | 152 | 5 | fce7d5a0617fc664b657f5bb9abb290e7cc234cb | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.84e-05 | 182 | 152 | 6 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.84e-05 | 182 | 152 | 6 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.95e-05 | 183 | 152 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.95e-05 | 183 | 152 | 6 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-05 | 183 | 152 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 184 | 152 | 6 | 89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 184 | 152 | 6 | 34c84ac9a32eaf96f45b79485119cad65905817d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.08e-05 | 184 | 152 | 6 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 4.08e-05 | 184 | 152 | 6 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-05 | 185 | 152 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-05 | 185 | 152 | 6 | ef3c1fd52d21d96f81fb0e5097b24be0ce16e222 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-05 | 185 | 152 | 6 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-05 | 185 | 152 | 6 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.20e-05 | 185 | 152 | 6 | c357fa098b561da16c9fa82b0c3563b5cd3fa875 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.20e-05 | 185 | 152 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-05 | 186 | 152 | 6 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-05 | 186 | 152 | 6 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.33e-05 | 186 | 152 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.33e-05 | 186 | 152 | 6 | 701eea0016d69f0f9d29b613948f91239096e6c7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.33e-05 | 186 | 152 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-05 | 186 | 152 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.46e-05 | 187 | 152 | 6 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 4.46e-05 | 187 | 152 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-05 | 188 | 152 | 6 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 188 | 152 | 6 | 61f010c165826b434ca3d27553d4c9e13d2c0c51 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-05 | 188 | 152 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 188 | 152 | 6 | 7553ef7de3575af4cf34704b405b551c1af8eb83 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 188 | 152 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.60e-05 | 188 | 152 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-05 | 188 | 152 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-05 | 188 | 152 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 188 | 152 | 6 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.60e-05 | 188 | 152 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.73e-05 | 189 | 152 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-05 | 189 | 152 | 6 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-05 | 189 | 152 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.73e-05 | 189 | 152 | 6 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 4.73e-05 | 189 | 152 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.73e-05 | 189 | 152 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.69e-05 | 49 | 100 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Drug | cellobiitol | 1.45e-07 | 37 | 150 | 6 | CID000003871 | |
| Drug | rioprostil | 2.03e-06 | 32 | 150 | 5 | CID005311413 | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.49e-06 | 188 | 150 | 9 | 6735_DN | |
| Drug | Dydrogesterone [152-62-5]; Up 200; 12.8uM; HL60; HT_HG-U133A | 6.57e-06 | 197 | 150 | 9 | 2156_UP | |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; PC3; HT_HG-U133A | 6.57e-06 | 197 | 150 | 9 | 5851_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.57e-06 | 197 | 150 | 9 | 7231_DN | |
| Drug | fullerene C60 | SOX6 ATXN2L ARHGEF28 GPBP1 RASGRF1 HJURP GPATCH2 PER1 POU2F1 MUC5B ZHX2 CREBBP NFIX MTM1 ERRFI1 NFRKB BSN PYCR2 MUC4 TNS1 MUC6 WNK4 PRRC2B DYRK2 PDZD2 | 1.55e-05 | 1498 | 150 | 25 | ctd:C069837 |
| Drug | Gastrin tetrapeptide | 1.94e-05 | 50 | 150 | 5 | CID000005415 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 2.07e-05 | 174 | 150 | 8 | 1302_UP | |
| Drug | guanidine hydrochloride | 2.39e-05 | 129 | 150 | 7 | CID000005742 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.44e-05 | 178 | 150 | 8 | 3998_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.54e-05 | 179 | 150 | 8 | 4585_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 3.22e-05 | 185 | 150 | 8 | 1673_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.74e-05 | 189 | 150 | 8 | 4271_DN | |
| Drug | Contact Lens Solutions | 4.31e-05 | 2 | 150 | 2 | ctd:D018639 | |
| Drug | PMME | 4.31e-05 | 2 | 150 | 2 | CID000439436 | |
| Drug | STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A | 4.34e-05 | 193 | 150 | 8 | 6869_DN | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 4.67e-05 | 195 | 150 | 8 | 1706_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; HL60; HT_HG-U133A | 4.85e-05 | 196 | 150 | 8 | 2969_UP | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 5.39e-05 | 199 | 150 | 8 | 5817_DN | |
| Disease | cholangiocarcinoma (is_marker_for) | 9.54e-07 | 64 | 151 | 6 | DOID:4947 (is_marker_for) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.30e-06 | 5 | 151 | 3 | DOID:3030 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.55e-05 | 61 | 151 | 5 | DOID:3587 (is_marker_for) | |
| Disease | spinocerebellar ataxia type 2 (implicated_via_orthology) | 2.60e-05 | 2 | 151 | 2 | DOID:0050955 (implicated_via_orthology) | |
| Disease | obsolete aging | 1.00e-04 | 279 | 151 | 8 | GO_0007568 | |
| Disease | QT interval | ATXN2L ARHGEF28 TRPM7 CREBBP PDLIM5 KIAA1755 ZFHX3 HERPUD2 ARHGAP21 CAP2 PRRC2B | 1.01e-04 | 534 | 151 | 11 | EFO_0004682 |
| Disease | resting heart rate | 1.22e-04 | 149 | 151 | 6 | EFO_0004351 | |
| Disease | atrial fibrillation | NACA CEP68 CNTN5 KIAA1755 ZFHX3 MYOCD ARHGAP21 CRAMP1 PHLDB2 | 1.31e-04 | 371 | 151 | 9 | EFO_0000275 |
| Disease | heart rate | 1.66e-04 | 225 | 151 | 7 | EFO_0004326 | |
| Disease | chronotype measurement | SOX6 TANC2 TSHZ3 PER1 USP31 AXDND1 UBXN4 FAM193A CNTN5 TET1 CAMTA1 BSN MUC1 ST18 | 1.84e-04 | 882 | 151 | 14 | EFO_0008328 |
| Disease | PR interval | CARMIL1 PDLIM5 HIVEP3 ZNF469 MTUS1 KIAA1755 MYOCD CAMTA1 HERPUD2 PHLDB2 | 2.46e-04 | 495 | 151 | 10 | EFO_0004462 |
| Disease | lung carcinoma (is_marker_for) | 2.58e-04 | 5 | 151 | 2 | DOID:3905 (is_marker_for) | |
| Disease | reticulocyte count | SOX6 UBAP2 ARHGEF28 KBTBD8 ZHX2 FAM83C ZNF469 ATXN2 CNTN5 NFRKB ASXL2 BSN TNS1 MYBL2 PDZD2 | 3.18e-04 | 1045 | 151 | 15 | EFO_0007986 |
| Disease | reticulocyte measurement | SOX6 UBAP2 ARHGEF28 KBTBD8 PER1 FAM83C ZNF469 ATXN2 CNTN5 ASXL2 BSN TNS1 ARHGAP21 MYBL2 PDZD2 | 3.45e-04 | 1053 | 151 | 15 | EFO_0010700 |
| Disease | Sezary Syndrome | 3.51e-04 | 27 | 151 | 3 | C0036920 | |
| Disease | neuroimaging measurement | ATXN2L UBAP2 CARMIL1 ZHX2 ZNF469 SNAP91 ATXN2 PRRC2C IQCJ NFIX TLE4 KIAA1755 IQCJ-SCHIP1 CAMTA1 TNS1 | 4.03e-04 | 1069 | 151 | 15 | EFO_0004346 |
| Disease | chemokine (C-C motif) ligand 27 measurement | 4.65e-04 | 70 | 151 | 4 | EFO_0008082 | |
| Disease | diastolic blood pressure, unipolar depression | 4.82e-04 | 30 | 151 | 3 | EFO_0003761, EFO_0006336 | |
| Disease | suberic acid measurement | 5.37e-04 | 7 | 151 | 2 | EFO_0010534 | |
| Disease | tissue factor pathway inhibitor measurement | 5.37e-04 | 7 | 151 | 2 | EFO_0007968 | |
| Disease | uterine fibroid | 5.78e-04 | 199 | 151 | 6 | EFO_0000731 | |
| Disease | total iron binding capacity | 7.01e-04 | 78 | 151 | 4 | EFO_0006334 | |
| Disease | triglyceride change measurement, response to long-chain n-3 PUFA dietary supplementation | 7.14e-04 | 8 | 151 | 2 | EFO_0007681, EFO_0009308 | |
| Disease | sporadic amyotrophic lateral sclerosis, survival time | 7.14e-04 | 8 | 151 | 2 | EFO_0000714, EFO_0001357 | |
| Disease | common bile duct neoplasm (is_marker_for) | 7.14e-04 | 8 | 151 | 2 | DOID:4608 (is_marker_for) | |
| Disease | tumor necrosis factor receptor II measurement | 7.14e-04 | 8 | 151 | 2 | EFO_0008384 | |
| Disease | pulse pressure measurement | SOX6 KLF8 TRPM7 TEX2 CARMIL1 COL27A1 FHOD3 PDLIM5 HIVEP3 CEP68 FAM193A GUCY1A1 TET1 KIAA1755 ZFHX3 IQCJ-SCHIP1 ST18 | 8.00e-04 | 1392 | 151 | 17 | EFO_0005763 |
| Disease | dry eye syndrome (is_marker_for) | 1.14e-03 | 10 | 151 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 1.14e-03 | 10 | 151 | 2 | DOID:10754 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 1.14e-03 | 10 | 151 | 2 | DOID:11204 (is_marker_for) | |
| Disease | uric acid measurement | TRPM7 CARMIL1 KBTBD8 GPATCH2 POLA2 F5 FMN1 ASXL2 MUC1 PRRC2B | 1.23e-03 | 610 | 151 | 10 | EFO_0004761 |
| Disease | Paroxysmal atrial fibrillation | 1.28e-03 | 156 | 151 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.28e-03 | 156 | 151 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.28e-03 | 156 | 151 | 5 | C2585653 | |
| Disease | RR interval | 1.30e-03 | 42 | 151 | 3 | EFO_0004831 | |
| Disease | Neurodevelopmental Disorders | 1.35e-03 | 93 | 151 | 4 | C1535926 | |
| Disease | growth rate measurement | 1.39e-03 | 11 | 151 | 2 | EFO_0010572 | |
| Disease | interleukin-6 measurement, response to stimulus | 1.39e-03 | 11 | 151 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Atrial Fibrillation | 1.43e-03 | 160 | 151 | 5 | C0004238 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.66e-03 | 12 | 151 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | right ventricular stroke volume measurement | 1.66e-03 | 12 | 151 | 2 | EFO_0021817 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.66e-03 | 12 | 151 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | electrocardiography | ATXN2L SPEG CARMIL1 FHOD3 PDLIM5 KIAA1755 MYOCD HERPUD2 MUC1 | 1.69e-03 | 530 | 151 | 9 | EFO_0004327 |
| Disease | Adenoid Cystic Carcinoma | 1.77e-03 | 100 | 151 | 4 | C0010606 | |
| Disease | anthropometric measurement | 1.77e-03 | 168 | 151 | 5 | EFO_0004302 | |
| Disease | pancreatic cancer (is_marker_for) | 1.83e-03 | 101 | 151 | 4 | DOID:1793 (is_marker_for) | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 1.96e-03 | 13 | 151 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | male infertility (implicated_via_orthology) | 1.96e-03 | 13 | 151 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Hypermetropia | 1.97e-03 | 103 | 151 | 4 | HP_0000540 | |
| Disease | Leukemia, Myelocytic, Acute | 2.01e-03 | 173 | 151 | 5 | C0023467 | |
| Disease | lifestyle measurement, depressive symptom measurement | 2.11e-03 | 105 | 151 | 4 | EFO_0007006, EFO_0010724 | |
| Disease | prostate carcinoma | TANC2 UBAP2 CHD3 EMSY PDLIM5 CEP350 ANLN FMN1 ZFHX3 MYOCD BSN CRAMP1 | 2.17e-03 | 891 | 151 | 12 | EFO_0001663 |
| Disease | myocardial infarction | 2.24e-03 | 350 | 151 | 7 | EFO_0000612 | |
| Disease | testosterone measurement | SOX6 ATXN2L PCYT1A KLF8 SPEM3 MAP1A PSD3 CEP68 RGS14 FAM186A ZFHX3 MYOCD ARHGAP21 CAP2 CNTFR | 2.34e-03 | 1275 | 151 | 15 | EFO_0004908 |
| Disease | Abnormality of refraction | TSHZ3 RASGRF1 RRP1B PCLO HIVEP3 SNAP91 NFIX ZFHX3 PEAK1 ST18 | 2.52e-03 | 673 | 151 | 10 | HP_0000539 |
| Disease | Down syndrome (implicated_via_orthology) | 2.61e-03 | 15 | 151 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.61e-03 | 15 | 151 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 2.61e-03 | 15 | 151 | 2 | C3645536 | |
| Disease | triacylglycerol 56:9 measurement | 3.36e-03 | 17 | 151 | 2 | EFO_0010436 | |
| Disease | lysophosphatidylcholine 18:1 measurement | 3.36e-03 | 17 | 151 | 2 | EFO_0010360 | |
| Disease | sphingomyelin 14:0 measurement | 3.36e-03 | 17 | 151 | 2 | EFO_0010390 | |
| Disease | otitis media (biomarker_via_orthology) | 3.36e-03 | 17 | 151 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | blood nickel measurement | 3.42e-03 | 120 | 151 | 4 | EFO_0007583 | |
| Disease | C-reactive protein measurement | SOX6 ATXN2L PCYT1A ARHGEF28 MAP1A CARMIL1 PSD3 IFI16 ZNF469 PAPOLA TLE4 CAMTA1 BSN ARHGAP21 | 3.68e-03 | 1206 | 151 | 14 | EFO_0004458 |
| Disease | disease progression measurement | 3.81e-03 | 61 | 151 | 3 | EFO_0008336 | |
| Disease | puberty onset measurement | 3.96e-03 | 125 | 151 | 4 | EFO_0005677 | |
| Disease | colorectal cancer | 4.03e-03 | 604 | 151 | 9 | MONDO_0005575 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 4.65e-03 | 20 | 151 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 4.67e-03 | 131 | 151 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 4.67e-03 | 131 | 151 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 4.67e-03 | 131 | 151 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 4.67e-03 | 131 | 151 | 4 | C3714758 | |
| Disease | breast carcinoma (is_marker_for) | 4.75e-03 | 66 | 151 | 3 | DOID:3459 (is_marker_for) | |
| Disease | intraocular pressure measurement | 4.82e-03 | 509 | 151 | 8 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSPSATTPLTKTHSQ | 591 | Q9P2B4 | |
| SPSSKQSVPETLSPS | 1276 | Q9Y6Y1 | |
| SPSISSTTSPKLNLP | 226 | Q8TF27 | |
| PISAKATQPSSANPT | 786 | A6NCI8 | |
| VSPASTLKSPTNVSP | 341 | Q76N32 | |
| RTQPPTTVSTGKPTS | 1926 | Q92793 | |
| SSKPATPKTTTPPSS | 141 | O75952 | |
| PLSKSSPATTVTSPN | 301 | O60641 | |
| SPATTVTSPNSTPAK | 306 | O60641 | |
| HPSQTTPAQKKTPSS | 156 | Q6UB98 | |
| PPATPAKHSSSTSSK | 601 | Q6W2J9 | |
| NLAAPSFPKTATTTP | 696 | P78312 | |
| PSSTLPAASSLKTPG | 916 | Q76L83 | |
| PLLSVNKSTSTPTSP | 671 | Q8WWM7 | |
| SATTKKSPPSQAPSN | 966 | O94779 | |
| PKSDSSSSLPKTNPT | 516 | Q8NCD3 | |
| PTVTSSKATPSSSPG | 1946 | Q9HC84 | |
| PPKVLTSTATTPTAT | 3021 | Q9HC84 | |
| TPSKTRTSTLLPSSP | 4101 | Q9HC84 | |
| PSSTAPKTPSLSSTQ | 581 | Q9H1K0 | |
| SSTHKQTSPVPSPLS | 511 | Q68DA7 | |
| SPSPPSVSSEKLSSS | 71 | Q1A5X6 | |
| SSSSNTTKKPEPPVN | 561 | O60271 | |
| SKPTLSALPSPVVTS | 121 | Q8N149 | |
| PQSSKHTLPTETSPS | 411 | Q8N1W1 | |
| PFTSPDKTLASPTSS | 56 | Q8WXI7 | |
| GSPKISSSPNLTSPA | 1366 | Q8WXI7 | |
| PPSVDKTSSPSSFLS | 5031 | Q8WXI7 | |
| TALSPSSLPPKISTA | 436 | Q99102 | |
| QTPLLPATLTSSKPT | 1251 | Q6W4X9 | |
| PSTSQTEASLSPPAK | 151 | Q6ZTZ1 | |
| SSTSPQLSKPSITPV | 31 | Q5JU00 | |
| ITSPPSTSTTKRPKS | 266 | Q14938 | |
| PSLDPLLSSSSAPTK | 1406 | Q8NEZ4 | |
| TKAPSLDSSLPQLPS | 2221 | P78559 | |
| PPQTSGLSPSRLSKS | 61 | Q9H063 | |
| TSTAQPVTPKPTSQA | 1131 | Q14676 | |
| PTTSTDQPVTPKLTS | 1621 | Q14676 | |
| SLSKSSPESPLQSPV | 841 | O60732 | |
| PASVSTVPSKLPTSS | 316 | Q7Z434 | |
| KPTSTISTSPPLIHS | 101 | Q8N387 | |
| SLPATASPVSKPATS | 881 | Q6P4R8 | |
| NSPQSSPTSTPKLSK | 321 | Q9Y6Y0 | |
| NSTAKPTVQPSPSTT | 121 | Q04900 | |
| SPKRSPTSSAIPLQS | 1241 | Q9ULD2 | |
| LNFPTPPSSTKSSLN | 11 | Q86WP2 | |
| QTKTSGPATAPSPLT | 521 | Q5JYT7 | |
| TSAKSCSPSPVSPQV | 91 | Q9NQW6 | |
| SSKPNSPSISPSILS | 856 | Q99700 | |
| PFKTKSSESPSSSPS | 706 | Q9Y3R5 | |
| ATTTPASKSTPFSIP | 981 | P15941 | |
| PICKTSDLTSTPSQP | 171 | Q9UPA5 | |
| VNGTPSSQLSTPKST | 321 | Q8N568 | |
| SPTKSHTPSPTSPKS | 301 | P40123 | |
| QASSSSKAPPPSLPS | 136 | P0DN87 | |
| KSTNSQSPSPPSSSI | 91 | O15534 | |
| TTPPLKTDSAKPSQS | 791 | Q9Y6V0 | |
| LQAISPKQSPSSSPT | 311 | P49585 | |
| LQALSPKQSPVSSPT | 311 | Q9Y5K3 | |
| QSLPKASPVTTSPTA | 31 | Q96JN0 | |
| SLPPTSPLVSTAKTA | 741 | Q02505 | |
| TKLVSPSLTPCSTPT | 671 | O15018 | |
| PKTKSSSSTPNSPVT | 496 | Q9H792 | |
| VTPSPSKLVTSPQSE | 851 | Q9H792 | |
| PSTQPTSTVKNSPRS | 166 | P34910 | |
| ISKSPLASPAPQSTS | 1796 | Q92817 | |
| QTKPSISQISTTLPP | 76 | Q8NC54 | |
| PKPQSSPQTLVVSTS | 111 | O95600 | |
| APSASSTPTIIASPK | 421 | P34903 | |
| TKAVTTNSPLPPSLT | 806 | Q9ULI3 | |
| SSPKVTSIPSPSSAF | 136 | Q96HC4 | |
| SSSTPLSNTPLSPVK | 336 | Q8IZQ8 | |
| SSSPIKAIFPSPTSL | 446 | P14859 | |
| DLSKSSPTPNGIPSS | 6 | Q8NFY9 | |
| KQTTTPATAPTTTAP | 376 | A6NF01 | |
| PSPTSATKTSPLNSS | 536 | P51003 | |
| SLPSKPSSTLNVPSN | 336 | Q9UNF0 | |
| KNLPPQSTTLLPTTS | 616 | Q5T0Z8 | |
| VNRSTKPNSSTPASP | 206 | Q8WV28 | |
| QPSSQSLTPVTPQKS | 251 | Q15329 | |
| SLPSSTSLSSIKQSP | 341 | Q9BQN1 | |
| KTSPTTPEASATNSP | 1536 | Q12873 | |
| MSLPKTPSTPLNSTS | 1 | Q5T1B0 | |
| STTSSLAPPPTTKIC | 321 | P26992 | |
| DSSKSLPSPSSSPQP | 1126 | Q96RY5 | |
| QSPISTPTSPGSLRK | 331 | O43602 | |
| SVQSIKSTLSAPTSP | 366 | Q2V2M9 | |
| TSPSANLKSPQTPSQ | 946 | Q86UU0 | |
| QKTPTSPLSPSSQKS | 1251 | Q5VT06 | |
| KSLPTKPSAPSTSIV | 366 | Q8IZC6 | |
| SPSPKTSLSAPPNSS | 166 | Q16666 | |
| STSISLSKPETPNPH | 866 | Q6UXX5 | |
| RSSSSTPTSPKPLLQ | 1246 | Q5VZK9 | |
| CTSRTPPSSPKSSTN | 86 | Q9BSE4 | |
| KPVTATLPTSSNSPI | 471 | Q7Z589 | |
| TSSTLKVLPGPSPQS | 346 | A6NE01 | |
| PLPKSTSATTTPNAG | 511 | Q9NW75 | |
| LSNALSKSSAPPITP | 41 | P05060 | |
| TSISKLPPPSSSASK | 561 | Q92630 | |
| ALSPCPSTVSTKSQP | 671 | Q08AD1 | |
| NVSTPETTLKPSLSP | 126 | P28906 | |
| SNPATPTSKLSLKTP | 126 | Q32NC0 | |
| SSTSPENITSPPLKL | 436 | A6NGG8 | |
| NTTIKSNPTSTPTVP | 4116 | Q685J3 | |
| VSSKPTTPTIATPQT | 151 | Q9HBM6 | |
| PSSAISTATPSPKST | 766 | O14607 | |
| LKTPTSSPASSPLVA | 726 | Q14684 | |
| PKSPEKLPQSSSSES | 406 | Q9UQ35 | |
| KLPQSSSSESSPPSP | 411 | Q9UQ35 | |
| SSSESSPPSPQPTKV | 416 | Q9UQ35 | |
| PSPSSPTLNDTFLSK | 1491 | P12259 | |
| NPAIPESTPSTLKNS | 221 | Q1AE95 | |
| TLPKSLSLPTTAPSN | 601 | P10244 | |
| TTSQSSKQPPPSIRL | 1946 | Q9Y520 | |
| PCSTLPPISTNATAK | 146 | Q9HCD6 | |
| KLESPTVSTLTPSSP | 291 | Q96C36 | |
| STLSKLPTPTSSVPA | 286 | Q9BTA9 | |
| LSPSSFSPSATPSQK | 146 | Q14181 | |
| SPSPPSVSSEKLSSS | 71 | B3KU38 | |
| KPPTPLLNTTSSLSG | 106 | Q86SQ0 | |
| PPLASPSVFTSTLSK | 711 | Q17R89 | |
| KFSSPPPLSITKTSS | 736 | Q13972 | |
| SPSNSRTPSPKSLPS | 326 | Q9UJM3 | |
| KSAPLTSSNTSIPTP | 626 | O60284 | |
| SIPTPSSSPFKTSSI | 636 | O60284 | |
| TSPTQNLFPASKTSP | 441 | P35712 | |
| TPQSSSNSEKNSLPP | 476 | Q8NFU7 | |
| STKPSLSLTTSPKPA | 141 | Q6ZU45 | |
| QSRSPSVSPSKQPVS | 491 | Q96JG6 | |
| SQQTLDTPKTTGPPS | 651 | Q5T6F2 | |
| SSSSSSSQAKKPDPP | 111 | P0CJ78 | |
| NPAIPESTPSTLKNS | 221 | Q8IXX5 | |
| LANSAKLSDPPTSPS | 576 | Q13496 | |
| STTVKSSSKPSPPSE | 1361 | Q15772 | |
| IQTPTVLPTSKSPQS | 621 | A0A1B0GUW6 | |
| SIPPTPTLTSTAVKS | 1101 | Q9UJ98 | |
| STTPVSKSNTPTPRT | 316 | Q04727 | |
| TATTKVPLSTEPPQS | 251 | Q76KD6 | |
| TPKRPSTSQTVSTPA | 641 | P12270 | |
| SKSPASSSLPAFLPT | 811 | Q9HBL0 | |
| EPQPSSSKPSAKSSL | 1071 | Q5T1R4 | |
| QAKPTPVSPATSSAS | 176 | P28908 | |
| PKSSSATASQPPESL | 96 | Q5JSZ5 | |
| PASPSSLVKVPSSAT | 476 | O43566 | |
| TFTSPSNTPASISPK | 451 | Q63HK5 | |
| PSSTACPKPSVLSSK | 1306 | Q96JG9 | |
| PDPSPSSKLSSVASN | 126 | Q96F45 | |
| QLTSSLPSPSPAIAK | 621 | Q9Y6X8 | |
| SSLSSTSPSSPLPVK | 1051 | Q70CQ4 | |
| SSPLSSPSKSPILSS | 161 | Q8IWB9 | |
| VTSSEPPNPASSSKS | 446 | Q92575 | |
| SPPDSSLSKQQTSTP | 221 | Q5T5U3 | |
| SSPSLNPDTSPITAK | 1011 | Q9NYI0 | |
| QPTPSSSATQSKPTP | 16 | P61964 | |
| SPKPSTPQLTSESSD | 1041 | Q96J92 | |
| AQSPPSSSLTATPQK | 281 | Q8WY91 | |
| SSSLTATPQKPSQSP | 286 | Q8WY91 | |
| SSSTSIPHLSSPPTK | 1386 | Q96QT4 | |
| PSSKNSSPNSSPRTL | 1186 | P35125 | |
| FQPSQPLSKSSSSPE | 1376 | P49815 | |
| PSESKTPSPQLCTSS | 1096 | Q5TIE3 | |
| NKPSSASLSSPTPAQ | 3171 | Q15911 | |
| STKPSLSPSKPQSSL | 261 | Q02108 | |
| LSPSKPQSSLVIPTS | 266 | Q02108 | |
| PNSKDTTPAPPTTTS | 4476 | Q9UKN1 | |
| SLSPTTSLILKSSPN | 406 | E9PAV3 |